Nephrocare Health Services, operating as NephroPlus, has filed its Red Herring Prospectus to launch an initial public offering (IPO) on December 10.
The IPO will comprise a fresh issue of shares worth ₹353.4 crore along with an offer-for-sale of up to 1.12 crore shares by existing investors.
The company plans to use around ₹129.1 crore to set up new dialysis centres, ₹136 crore to repay debt, and the remainder for general corporate purposes.
With 519 clinics across India, NephroPlus is Asia’s largest dialysis service provider, aiming to strengthen its presence nationwide.